Gene therapy shows promise in glaucoma research
Reduction of NMNAT2 increases retinal ganglion cell susceptibility to injury. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-50354-5 Pete Williams is one of few researchers in Sweden concentrating on glaucoma. The goal
